G
Gaochao Zhou
Researcher at Merck & Co.
Publications - 51
Citations - 10970
Gaochao Zhou is an academic researcher from Merck & Co.. The author has contributed to research in topics: Agonist & Peroxisome proliferator-activated receptor. The author has an hindex of 31, co-authored 51 publications receiving 10177 citations.
Papers
More filters
Journal ArticleDOI
Role of AMP-activated protein kinase in mechanism of metformin action
Gaochao Zhou,Robert W. Myers,Ying Li,Yuli Chen,Xiaolan Shen,Judy Fenyk-Melody,Margaret Wu,John Ventre,Thomas W. Doebber,Nobuharu Fujii,Nicolas Musi,Michael F. Hirshman,Laurie J. Goodyear,David E. Moller +13 more
TL;DR: It is reported that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidation is induced, and expression of lipogenic enzymes is suppressed.
Journal ArticleDOI
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Bei B. Zhang,Gaochao Zhou,Cai Li +2 more
TL;DR: Genetic and pharmacological studies demonstrate that AMPK is required for maintaining glucose homeostasis and holds a considerable potential to reverse the metabolic abnormalities associated with type 2 diabetes.
Journal ArticleDOI
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
Nicolas Musi,Michael F. Hirshman,Jonas Nygren,Monika Svanfeldt,Peter Båvenholm,Olav Rooyackers,Gaochao Zhou,Joanne M. Williamson,Olle Ljunqvist,Suad Efendic,David E. Moller,Anders Thorell,Laurie J. Goodyear +12 more
TL;DR: The findings suggest that the metabolic effects of metformin in subjects with type 2 diabetes may be mediated by the activation of AMPK alpha2, which is implicated in the stimulation of glucose uptake into skeletal muscle and the inhibition of liver gluconeogenesis.
Journal ArticleDOI
27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.
Xuan Fu,John G. Menke,Yuli Chen,Gaochao Zhou,Karen L. MacNaul,Samuel D. Wright,Carl P. Sparrow,Erik G. Lund +7 more
TL;DR: 27-hydroxylation of cholesterol is an important pathway for LXR activation in response to cholesterol overload, and is concluded that 27-hydroxycholesterol functionally activated LXR.
Journal ArticleDOI
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Alessandro Pocai,Paul E. Carrington,Jennifer R. Adams,Michael Wright,George J. Eiermann,Lan Zhu,Xiaobing Du,Aleksandr Petrov,Michael E. Lassman,Guoqiang Jiang,Franklin Liu,Corey N. Miller,Laurie Tota,Gaochao Zhou,Xiaoping Zhang,Michael M. Sountis,Alessia Santoprete,Elena Capito,Gary G. Chicchi,Nancy A. Thornberry,Elisabetta Bianchi,Antonello Pessi,Donald J. Marsh,Ranabir SinhaRoy +23 more
TL;DR: Sustained GLP1R/GCGR dual agonism reverses obesity in DIO mice and is a novel therapeutic approach to the treatment of obesity.